OncoMatch

OncoMatch/Clinical Trials/NCT06856447

The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

Is NCT06856447 recruiting? Yes, currently enrolling (Jun 2026). This Phase 1 trial studies multiple treatments for colorectal cancer.

Phase 1Recruitingtoqa saad mohammed mohammedNCT06856447Data as of Jun 2026Location: Egypt

Treatment: Coenzyme Q10 · Oxaliplatin · 5-Fluorouracil (5-FU) · 5-HT3 Antagonist · PantoprazoleThis study aims to evaluate the possible beneficial role of coenzyme Q10 against oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.

Check if I qualify

Extracted eligibility criteria

Treatments studied

Chemotherapy

Oxaliplatin5-Fluorouracil (5-FU)

Other

Coenzyme Q105-HT3 AntagonistPantoprazole

Cancer type

Colorectal Cancer

Disease stage

Required: Stage III

Performance status

ECOG 0–1(Restricted strenuous activity)

Prior therapy

Cannot have received: neurotoxic agent (cisplatin, vincristine, paclitaxel, docetaxol, foscarnet, INH)

Patients with prior exposure to neurotoxic agents (Cisplatin, vincristine, paclitaxel, docetaxol, foscarnet, INH, etc..) in the last 6 months.

Lab requirements

Blood counts

absolute neutrophilic count ≥ 1.5 × 10^9 /L, platelet count ≥ 100 × 10^9 /L and hemoglobin level ≥ 10 g/dl

Kidney function

serum creatinine < 1.5 mg/dl

Liver function

serum bilirubin < 1.2 mg/dl

Adequate baseline hematologic values (absolute neutrophilic count ≥ 1.5 × 10^9 /L, platelet count ≥ 100 × 10^9 /L and hemoglobin level ≥ 10 g/dl). Patients with adequate renal function (serum creatinine < 1.5 mg/dl). Patients with adequate liver function (serum bilirubin < 1.2 mg/dl).

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT06856447 currently recruiting?

Yes, this trial is currently recruiting patients.

Are there prior therapy exclusions?

Yes. Prior neurotoxic agent disqualifies patients from enrollment.

What disease stage is eligible?

Stage III is required.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify